Dronabinol Safe and Effective for Neuropathic Pain Associated With Multiple Sclerosis
Pain intensity was not significantly reduced by dronabinol, compared with placebo after 16 weeks of treatment.
Oral vitamin E supplementation consisting of 400 mg/day mixed tocotrienols for 1 year may not result in improved neuropathic pain symptoms in patients with diabetic peripheral neuropathy.
An examination of treatment patterns among patients with trigeminal neuralgia suggests that this orofacial disorder appears to be significantly burdensome.
Microvascular decompression for trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia was found to be a largely safe procedure.